John Hancock Tax Advantaged Dividend Income Fund is a US-based company operating in industry. The company is headquartered in Boston, Massachusetts. The company went IPO on 2004-02-25. John Hancock Tax-Advantaged Dividend Income Fund (the fund) is a closed-end management investment company. The fund seeks to provide a high level of after-tax total return from dividend income and capital appreciation. The company invests in utilities, financials, energy, communication services, real estate, information technology, materials, consumer staples, United States government agency, and short-term investments. John Hancock Investment Management LLC (the Advisor) serves as investment advisor for the fund.
John Hancock Tax Advantaged Dividend Income Fund 的关键财务报表是什么?
根据最新的财务报表(Form-10K),Drugs Made In America Acquisition II Corp 的总资产为 $0,净亏损为 $0
HTD 的关键财务比率是什么?
Drugs Made In America Acquisition II Corp 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
John Hancock Tax Advantaged Dividend Income Fund 的收入按细分市场或地理位置如何划分?
Drugs Made In America Acquisition II Corp 最大收入来源是 Casualty,在最近的收益报告中收入为 390,565,000。就地区而言, United States 是 Drugs Made In America Acquisition II Corp 的主要市场,收入为 581,530,000。
John Hancock Tax Advantaged Dividend Income Fund 是否盈利?
否,根据最新的财务报表,Drugs Made In America Acquisition II Corp 的净亏损为 $0
John Hancock Tax Advantaged Dividend Income Fund 有负债吗?
否,Drugs Made In America Acquisition II Corp 的负债为 0
John Hancock Tax Advantaged Dividend Income Fund 的流通股有多少?
Drugs Made In America Acquisition II Corp 的总流通股为 0